Amino Acid, Peptide, or Protein
Sanofi Discontinues mRNA Seasonal Flu Vaccine Development, Focuses on Existing Vaccines Amid CEO Confidence
Sanofi; mRNA flu vaccine; seasonal flu; vaccine discontinuation; Paul Hudson; Fluzone; Flublok
Friday Five: Sanofi and Roche Face Headwinds Amid US Pricing Pressures and 2026 Drug Pipeline Shifts
Sanofi; Roche; vaccines; weight loss drugs; US pricing pressures; 2026 outlook
Vera Therapeutics Appoints Matt Skelton as Chief Commercial Officer
Vera Therapeutics; Matt Skelton; Chief Commercial Officer; atacicept; IgA nephropathy; biotechnology
Eli Lilly Partners with Seamless Therapeutics on Up to $1.12B Recombinase Gene Editing Deal for Hearing Loss
Eli Lilly; Seamless Therapeutics; recombinase; gene editing; hearing loss; collaboration; $1.12B
Boehringer Ingelheim Signs $1.3 Billion Deal for Simcere’s Preclinical IBD Bispecific SIM0709
Boehringer Ingelheim; Simcere; SIM0709; IBD; bispecific antibody; TL1A; IL-23p19; licensing deal
Novo Nordisk’s Wegovy Pill Launches Strongly Amid Analyst Caution
Wegovy pill; Novo Nordisk; FDA approval; oral GLP-1; obesity drug; Eli Lilly competition
Sanofi’s Amlitelimab Shows Mixed Phase 3 Results in Eczema Trials, Clouds Blockbuster Hopes but Advances to Regulatory Filings
Sanofi; amlitelimab; Phase 3; eczema; atopic dermatitis; COAST; SHORE; vIGA-AD; EASI-75
Corxel Pharmaceuticals Raises $287M Series D1 to Advance Oral GLP-1 Obesity Drug CX11
Corxel Pharmaceuticals; Series D1; GLP-1; CX11; obesity drug; funding; Vincentage
BioMarin Veterans Launch Mendra Biotech with $82M for AI-Driven Rare Disease Drugs
Mendra; BioMarin; rare disease; biotech startup; $82M; Series A; AI drug development
J&J Targets $100 Billion in 2026 Sales Despite Stelara Patent Cliff
Johnson & Johnson; J&J; 2026 sales; $100 billion; Stelara; patent cliff; DARZALEX; oncology; MedTech; Shockwave Medical